Clinical trials for advancing innovative interventions for neurodegenerative diseases[E8]

Aus der Bekanntmachung

Call: Cluster 1 - Health (Two stage - 2027). Type of action: HORIZON Research and Innovation Actions. Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes: The scientific and clinical communities make effective use of state-of-the-art knowledge, data, technologies, tools, methods, best practices, and trainings to underpin and complement the development of innovative interventions aimed at more effective treatments for neurodegenerative diseases. The scientific and clinical communities benefit from the exchange of data, knowledge and best practices, thereby strengthening their collaboration in the EU, the Associated Countries and beyond. The scientific and clinical communities make wide use of relevant databases and/or integrate them with existing infrastructures for storage and sharing of collected data according to FAIR [1] principles, thereby encouraging further use of the data. Policymakers, funders, scientific and clinical communities, patient organisations, regulators, and other relevant bodies are informed of the research advances made and the requirements for a widespread implementation of the innovative therapeutic interventions and complementary approaches. Patients and caregivers are constructively engaged with the research, ensuring that their needs are catered for…[E3]

Die Angaben der Bekanntmachung werden so gezeigt, wie die Quelle sie veröffentlicht hat. Die Fakten und Anforderungen, die wir herausziehen, sind auf Englisch.

• Offen fürUniversities and research. Von SLETOR anhand der Wörter der Ausschreibung zugeordnet.
• BedingungEU grant rules apply: check the call conditions for who can apply, consortium rules and co-funding.[E4]

• RisikoThis is a grant, not a contract. Grants usually need a proposal against the funder's criteria, may need partners and often need co-funding.[E5]
• UnbekanntWe read the funder's listing, not the full guidance or application forms.

1. Für Angebote geöffnet · 29. Okt. 2026, 07:41 UTC

   The funder published the call with a future closing date.

   Geändert: status, notice type, published at (Quelldatensatz Clinical trials for advancing innovative interventions for neurodegenerative di… (ID HORIZON-HLTH-2027-02-DISEASE-14-two-stage))

2. Erstmals gesehen · 28. Okt. 2026, 21:22 UTC

   The funder announced the call. Applications have not opened yet.

   Quelldatensatz: Clinical trials for advancing innovative interventions for neurodegenerative di… (ID HORIZON-HLTH-2027-02-DISEASE-14-two-stage)

Jede Angabe auf dieser Seite stammt aus der Ausschreibung des Fördergebers. Jeder Eintrag zeigt den Datensatz und das Feld, aus dem er gelesen wurde.

1. E1

   The funder is European Commission.

   Aus Clinical trials for advancing innovative interventions for neurodegenerative di… (ID HORIZON-HLTH-2027-02-DISEASE-14-two-stage), Feld /metadata/type/0, gelesen 29. Okt. 2026, 07:41 UTC · Quelle ↗ (öffnet in neuem Tab)

2. E2

   Proposals must be submitted by 17 Feb 2027, 01:00 Central European time (UTC+1).

   “2027-02-17T00:00:00.000+0000”

   Aus Clinical trials for advancing innovative interventions for neurodegenerative di… (ID HORIZON-HLTH-2027-02-DISEASE-14-two-stage), Feld /metadata/deadlineDate/0, gelesen 29. Okt. 2026, 07:41 UTC · Quelle ↗ (öffnet in neuem Tab)

3. E3

   The buyer describes the requirement in the notice.

   “Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to deliver results that are directed…”

   Aus Clinical trials for advancing innovative interventions for neurodegenerative di… (ID HORIZON-HLTH-2027-02-DISEASE-14-two-stage), Feld /metadata/descriptionByte/0, gelesen 29. Okt. 2026, 07:41 UTC · Quelle ↗ (öffnet in neuem Tab)

4. E4

   EU grant rules apply: check the call conditions for who can apply, consortium rules and co-funding.

   “EU call topic”

   Aus Clinical trials for advancing innovative interventions for neurodegenerative di… (ID HORIZON-HLTH-2027-02-DISEASE-14-two-stage), Feld /metadata/type/0, gelesen 29. Okt. 2026, 07:41 UTC · Quelle ↗ (öffnet in neuem Tab)

5. E5

   This is an EU call for proposals.

   “31094502”

   Aus Clinical trials for advancing innovative interventions for neurodegenerative di… (ID HORIZON-HLTH-2027-02-DISEASE-14-two-stage), Feld /metadata/status/0, gelesen 29. Okt. 2026, 07:41 UTC · Quelle ↗ (öffnet in neuem Tab)

6. E6

   Applications open on 29 Oct 2026.

   “2026-10-29T00:00:00.000+0000”

   Aus Clinical trials for advancing innovative interventions for neurodegenerative di… (ID HORIZON-HLTH-2027-02-DISEASE-14-two-stage), Feld /metadata/startDate/0, gelesen 29. Okt. 2026, 07:41 UTC · Quelle ↗ (öffnet in neuem Tab)

7. E7

   The Funding & Tenders Portal gives the status as open for submission.

   Aus Clinical trials for advancing innovative interventions for neurodegenerative di… (ID HORIZON-HLTH-2027-02-DISEASE-14-two-stage), Feld /metadata/status/0, gelesen 29. Okt. 2026, 07:41 UTC · Quelle ↗ (öffnet in neuem Tab)

8. E8

   The notice is titled "Clinical trials for advancing innovative interventions for neurodegenerative diseases".

   Aus Clinical trials for advancing innovative interventions for neurodegenerative di… (ID HORIZON-HLTH-2027-02-DISEASE-14-two-stage), Feld /metadata/title/0, gelesen 29. Okt. 2026, 07:41 UTC · Quelle ↗ (öffnet in neuem Tab)

9. E9

   The EU contribution per grant is up to EUR 10,000,000 (from EUR 5,000,000).

   Aus Clinical trials for advancing innovative interventions for neurodegenerative di… (ID HORIZON-HLTH-2027-02-DISEASE-14-two-stage), Feld /metadata/budgetOverview/0, gelesen 29. Okt. 2026, 07:41 UTC · Quelle ↗ (öffnet in neuem Tab)

Source: EU Funding & Tenders Portal, © European Union, CC BY 4.0. SLETOR shortened and reformatted the text. Datenlizenz: Creative Commons Attribution 4.0 (European Commission) ↗ (öffnet in neuem Tab). Persönliche Kontaktdaten aus Bekanntmachungen werden weder gespeichert noch angezeigt.